Transmission, Blood, Recipient/Donor
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
HaemoneticsMA - Boston
3 programsOrthoPat AdvanceN/A1 trial
POLFAN/A1 trial
Procedure For The Reference Range Study For Absolute MAN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
HaemoneticsPOLFA
HaemoneticsProcedure For The Reference Range Study For Absolute MA
HaemoneticsOrthoPat Advance
Clinical Trials (3)
Total enrollment: 307 patients across 3 trials
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
Start: Jun 2015Est. completion: Sep 201562 patients
N/ACompleted
Procedure For The Reference Range Study For Absolute MA
Start: May 2014Est. completion: Mar 2015161 patients
N/ACompleted
Clinical Evaluation of the OrthoPAT Advance System
Start: Dec 2012Est. completion: Aug 201384 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.